SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009692
Filing Date
2022-05-12
Accepted
2022-05-12 16:25:12
Documents
63
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q harp-20220331.htm   iXBRL 10-Q 2795555
2 EX-10.1 harp-ex10_1.htm EX-10.1 202135
3 EX-10.2 harp-ex10_2.htm EX-10.2 42647
4 EX-31.1 harp-ex31_1.htm EX-31.1 14774
5 EX-31.2 harp-ex31_2.htm EX-31.2 14772
6 EX-32.1 harp-ex32_1.htm EX-32.1 12268
  Complete submission text file 0000950170-22-009692.txt   9596829

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT harp-20220331_cal.xml EX-101.CAL 41703
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT harp-20220331_pre.xml EX-101.PRE 286704
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT harp-20220331_def.xml EX-101.DEF 174344
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT harp-20220331_lab.xml EX-101.LAB 395581
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT harp-20220331.xsd EX-101.SCH 45913
57 EXTRACTED XBRL INSTANCE DOCUMENT harp-20220331_htm.xml XML 1924334
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 22918214
SIC: 2836 Biological Products, (No Diagnostic Substances)